Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

The 26th International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI) brought together the ...

Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, ...

After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

Breakthrough T1D North Texas and Oklahoma, formerly known as JDRF, hosted the Breakthrough T1D Walk at Hunter Park in Tulsa ...

Johnson & Johnson said its nipocalimab treatment for adults living with moderate-to-severe Sjögren's disease has received breakthrough therapy designation from the Food and Drug Administration.

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...